|
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer |
|
|
|
Title: |
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer |
Author: |
Tanaka, Hisashi Taima, Kageaki Itoga, Masamichi Ishioka, Yoshiko Baba, Keisuke Shiratori, Toshihiro Sakamoto, Hiroaki Tsuchiya, Junichiro Nakagawa, Hideyuki Hasegawa, Yukihiro Yasugahira, Hideo Okudera, Koichi Takanashi, Shingo Tasaka, Sadatomo |
Appeared in: |
Medical oncology |
Paging: |
Volume 36 (2019) nr. 6 pages 1-8 |
Year: |
2019 |
Contents: |
|
Publisher: |
Springer US, New York |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|